Acute myeloid leukemia (AML) starts in the bone marrow, which is the soft inner parts of bones. With acute types of leukemia, such as AML, bone marrow cells do not mature. These immature cells, often called blast cells, keep building up. Without treatment, AML can quickly become life-threatening. Because it is an acute type of leukemia, it can spread quickly to the blood and to other parts of the body, such as lymph nodes, liver, spleen, brain, spinal cord, and testicles. • According to 2018 report by World Cancer Research Fund, there were a total of 437,033 leukemia cases recorded, worldwide, in 2018. Out of these, more than 160,000 are estimated to be from the Asia-pacific region. AML is one of the major types of leukemia in the Asia-pacific region, comprising of approximately 28% of leukemia patients in Asia-pacific. Hence, the estimated prevalence of AML in Asia-pacific is 1.4 per 100,000.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS